Download PDF
Semin Thromb Hemost 2018; 44(01): 070-080
DOI: 10.1055/s-0037-1605569
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

In Situ Endothelialization Promoted by SEMA4D and CXCL12 for Titanium-Based Biomaterials

Yuanyuan Cui
1   Key Laboratory of Advanced Technology of Materials, Southwest Jiaotong University, Chengdu, People's Republic of China
,
Feng Zhou
1   Key Laboratory of Advanced Technology of Materials, Southwest Jiaotong University, Chengdu, People's Republic of China
2   Institute of Aeronautics and Astronautics, University of Electronic Science and Technology of China, Chengdu, People's Republic of China
,
Lai Wei
1   Key Laboratory of Advanced Technology of Materials, Southwest Jiaotong University, Chengdu, People's Republic of China
,
Qiang Song
1   Key Laboratory of Advanced Technology of Materials, Southwest Jiaotong University, Chengdu, People's Republic of China
,
Jianying Tan
1   Key Laboratory of Advanced Technology of Materials, Southwest Jiaotong University, Chengdu, People's Republic of China
,
Zheng Zeng
1   Key Laboratory of Advanced Technology of Materials, Southwest Jiaotong University, Chengdu, People's Republic of China
,
Junying Chen
1   Key Laboratory of Advanced Technology of Materials, Southwest Jiaotong University, Chengdu, People's Republic of China
,
Nan Huang
1   Key Laboratory of Advanced Technology of Materials, Southwest Jiaotong University, Chengdu, People's Republic of China
› Author Affiliations
Further Information

Publication History

Publication Date:
24 November 2017 (online)

    Permissions and Reprints

Abstract

In situ endothelialization, aiming to create implantation surfaces capable of self-endothelialization, seems to be an extremely promising solution, particularly on those blood-contacting surfaces. In this research study, we immobilized the soluble semaphorin 4D (SEMA4D) and C-X-C motif chemokine ligand 12 (CXCL12) biomolecules together with heparin onto the metal-based biomaterial surfaces to achieve in situ endothelialization of modified samples both by stimulating the neighboring endothelial cells (ECs) migration and by capturing the circulating endothelial progenitor cells (EPCs) directly from the blood circulation. X-ray photoelectron spectroscopy data demonstrate the successful immobilization of SEMA4D and CXCL12. Due to the presence of heparin, hemocompatibility was also improved after modification. Although EC migration was mainly mediated by SEMA4D with the coordination of CXCL12, EC proliferation and haptotaxis property were also enhanced, while EC chemotaxis was slightly suppressed because the further immobilization of CXCL12 influences the release of SEMA4D. The results of the ex vivo EPC capturing assay indicated the mobilization of CXCL12 promotes EPC adhesion. In vivo implantation further demonstrated that CXCL12 cooperates with SEMA4D to promote a process of in situ endothelialization.

Keywords

in situ endothelialization - endothelial cell migration - endothelial progenitor cell - SEMA4D - CXCL12
 

  • References

  • 1 World Health Organization Global Status Report on Noncommunicable Diseases. 2014. Available at: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf . Accessed December 20, 2015
    PubMed
  • 2 Marmagkiolis K, Grines C, Bilodeau L. Current percutaneous treatment strategies for saphenous vein graft disease. Catheter Cardiovasc Interv 2013; 82 (03) 406-413
    CrossrefPubMedGoogle Scholar
  • 3 Simon HA, Ge L, Sotiropoulos F, Yoganathan AP. Numerical investigation of the performance of three hinge designs of bileaflet mechanical heart valves. Ann Biomed Eng 2010; 38 (11) 3295-3310
    CrossrefPubMedGoogle Scholar
  • 4 Wang JC, Carrié D, Masotti M. , et al. Primary endpoint results of the OMEGA Study: one-year clinical outcomes after implantation of a novel platinum chromium bare metal stent. Cardiovasc Revasc Med 2015; 16 (02) 65-69
    CrossrefPubMedGoogle Scholar
  • 5 Giglioli C, Cecchi E, Vladi L. , et al. Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred?. J Cardiol 2014; 63 (04) 296-301
    CrossrefPubMedGoogle Scholar
  • 6 Komiyama H, Takano M, Sawatani T, Munakata R, Murakami D, Hata N. Very late in-stent restenosis due to neoatherosclerosis in the second-generation everolimus-eluting stent. Angioscopy 2016; 2: 25-28
    CrossrefPubMedGoogle Scholar
  • 7 Khan NA, Butany J, Leong SW, Rao V, Cusimano RJ, Ross HJ. Mitral valve-sparing procedures and prosthetic heart valve failure: a case report. Can J Cardiol 2009; 25 (03) e86-e88
    CrossrefPubMedGoogle Scholar
  • 8 O'Brien B, Zafar H, Ibrahim A, Zafar J, Sharif F. Coronary Stent Materials and Coatings: A Technology and Performance Update. Ann Biomed Eng 2016; 44 (02) 523-535
    CrossrefPubMedGoogle Scholar
  • 9 Liu T, Liu S, Zhang K, Chen J, Huang N. Endothelialization of implanted cardiovascular biomaterial surfaces: The development from in vitro to in vivo. J Biomed Mater Res – Part A 2014; 102 (10) 3754-3772
    PubMedGoogle Scholar
  • 10 Melchiorri AJ, Hibino N, Fisher JP. Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts. Tissue Eng Part B Rev 2013; 19 (04) 292-307
    CrossrefPubMedGoogle Scholar
  • 11 Melchiorri AJ, Hibino N, Fisher JP. Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts. Tissue Eng Part B Rev 2013; 19 (04) 292-307
    CrossrefPubMedGoogle Scholar
  • 12 Hristov M, Weber C. Endothelial progenitor cells in vascular repair and remodeling. Pharmacol Res 2008; 58 (02) 148-151
    CrossrefPubMedGoogle Scholar
  • 13 de Mel A, Jell G, Stevens MM, Seifalian AM. Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 2008; 9 (11) 2969-2979
    CrossrefPubMedGoogle Scholar
  • 14 Yin Y, Zhao X, Fang Y. , et al. SDF-1α involved in mobilization and recruitment of endothelial progenitor cells after arterial injury in mice. Cardiovasc Pathol 2010; 19 (04) 218-227
    CrossrefPubMedGoogle Scholar
  • 15 Conrotto P, Valdembri D, Corso S. , et al. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 2005; 105 (11) 4321-4329
    CrossrefPubMedGoogle Scholar
  • 16 Basile JR, Afkhami T, Gutkind JS. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol 2005; 25 (16) 6889-6898
    CrossrefPubMedGoogle Scholar
  • 17 Norrby K. Low-molecular-weight heparins and angiogenesis. APMIS 2006; 114 (02) 79-102
    CrossrefPubMedGoogle Scholar
  • 18 Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 2000; 407 (6807): 1029-1034
    CrossrefPubMedGoogle Scholar
  • 19 Zhu L, Stalker TJ, Fong KP. , et al. Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29 (07) 1039-1045
    CrossrefPubMedGoogle Scholar
  • 20 Mou P, Zeng Z, Li Q. , et al. Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets. Blood 2013; 121 (20) 4221-4230
    CrossrefPubMedGoogle Scholar
  • 21 Zhu L, Bergmeier W, Wu J. , et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci U S A 2007; 104 (05) 1621-1626
    CrossrefPubMedGoogle Scholar
  • 22 Klement GL, Yip TT, Cassiola F. , et al. Platelets actively sequester angiogenesis regulators. Blood 2009; 113 (12) 2835-2842
    CrossrefPubMedGoogle Scholar
  • 23 Chatterjee M, Huang Z, Zhang W. , et al. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood 2011; 117 (14) 3907-3911
    CrossrefPubMedGoogle Scholar
  • 24 Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed Engl 2002; 41 (03) 391-412
    PubMedGoogle Scholar
  • 25 Yang Z, Tu Q, Wang J, Huang N. The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization. Biomaterials 2012; 33 (28) 6615-6625
    CrossrefPubMedGoogle Scholar
  • 26 Kenausis GL, Vo J, Elbert DL. , et al. Poly (L -lysine) - g -Poly (ethylene glycol) layers on metal oxide surfaces: attachment mechanism and effects of polymer architecture on resistance to protein adsorption. J Phys Chem B 2000; 104: 3298-3309
    CrossrefPubMedGoogle Scholar
  • 27 Fuss C, Palmaz JC, Sprague EA. Fibrinogen: structure, function, and surface interactions. J Vasc Interv Radiol 2001; 12 (06) 677-682
    CrossrefPubMedGoogle Scholar
  • 28 Blombäck B, Bark N. Fibrinopeptides and fibrin gel structure. Biophys Chem 2004; 112 (2-3): 147-151
    CrossrefPubMedGoogle Scholar
  • 29 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52 (11) 2745-2756
    CrossrefPubMedGoogle Scholar
  • 30 Yang Z, Tu Q, Maitz MF, Zhou S, Wang J, Huang N. Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices. Biomaterials 2012; 33 (32) 7959-7971
    CrossrefPubMedGoogle Scholar
  • 31 Larsen K, Cheng C, Tempel D. , et al. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. Eur Heart J 2012; 33 (01) 120-128
    CrossrefPubMedGoogle Scholar
  • 32 Lee B, Shafiq M, Jung Y, Park J, Kim SH. Characterization and preparation of bio-tubular scaffolds for fabricating artificial vascular grafts by combining electrospinning and a co-culture system. Macromol Res 2016; 24 (02) 131-142
    CrossrefPubMedGoogle Scholar
  • 33 Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357 (24) 2482-2494
    CrossrefPubMedGoogle Scholar
  • 34 Hartwig JH. Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol 1992; 118 (06) 1421-1442
    CrossrefPubMedGoogle Scholar
  • 35 Semple JW, Italiano Jr JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011; 11 (04) 264-274
    CrossrefPubMedGoogle Scholar
  • 36 White II GC, Rompietti R. Platelet secretion: indiscriminately spewed forth or highly orchestrated?. J Thromb Haemost 2007; 5 (10) 2006-2008
    CrossrefPubMedGoogle Scholar
  • 37 Li W, Johnson DJ, Esmon CT, Huntington JA. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol 2004; 11 (09) 857-862
    CrossrefPubMedGoogle Scholar
  • 38 Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med 2011; 17 (11) 1381-1390
    CrossrefPubMedGoogle Scholar
  • 39 Greinacher A. Platelet activation by heparin. Blood 2011; 117 (18) 4686-4687
    CrossrefPubMedGoogle Scholar
  • 40 Gao C, Boylan B, Fang J, Wilcox DA, Newman DK, Newman PJ. Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. Blood 2011; 117 (18) 4946-4952
    CrossrefPubMedGoogle Scholar
  • 41 Lin Q, Ding X, Qiu F, Song X, Fu G, Ji J. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer. Biomaterials 2010; 31 (14) 4017-4025
    CrossrefPubMedGoogle Scholar
  • 42 Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69 (01) 11-25
    CrossrefPubMedGoogle Scholar
  • 43 Sastry SK, Horwitz AF. Integrin cytoplasmic domains: mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling. Curr Opin Cell Biol 1993; 5 (05) 819-831
    CrossrefPubMedGoogle Scholar
  • 44 Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995; 11: 549-599
    CrossrefPubMedGoogle Scholar
  • 45 Tamagnone L, Artigiani S, Chen H. , et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999; 99 (01) 71-80
    CrossrefPubMedGoogle Scholar
  • 46 Tamagnone L, Comoglio PM. Signalling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol 2000; 10 (09) 377-383
    CrossrefPubMedGoogle Scholar
  • 47 Holland JD, Kochetkova M, Akekawatchai C, Dottore M, Lopez A, McColl SR. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Cancer Res 2006; 66 (08) 4117-4124
    CrossrefPubMedGoogle Scholar
  • 48 Albert PR, Robillard L. G protein specificity: traffic direction required. Cell Signal 2002; 14 (05) 407-418
    CrossrefPubMedGoogle Scholar
  • 49 Basile JR, Barac A, Zhu T, Guan KL, Gutkind JS. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 2004; 64 (15) 5212-5224
    CrossrefPubMedGoogle Scholar
  • 50 Ziegler ME, Hatch MM, Wu N, Muawad SA, Hughes CC. mTORC2 mediates CXCL12-induced angiogenesis. Angiogenesis 2016; 19 (03) 359-371
    CrossrefPubMedGoogle Scholar
  • 51 Chung CA, Chen CY. The effect of cell sedimentation on measuring chondrocyte population migration using a Boyden chamber. J Theor Biol 2009; 261 (04) 610-625
    CrossrefPubMedGoogle Scholar
  • 52 Feil C, Augustin HG. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun 1998; 247 (01) 38-45
    CrossrefPubMedGoogle Scholar
  • 53 Peichev M, Naiyer AJ, Pereira D. , et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95 (03) 952-958
    CrossrefPubMedGoogle Scholar
  • 54 Avci-Adali M, Ziemer G, Wendel HP. Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization--a review of current strategies. Biotechnol Adv 2010; 28 (01) 119-129
    CrossrefPubMedGoogle Scholar
  • 55 Miller-Kasprzak E, Jagodziński PP. Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp (Warsz) 2007; 55 (04) 247-259
    CrossrefPubMedGoogle Scholar
  • 56 Yu J, Wang A, Tang Z. , et al. The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration. Biomaterials 2012; 33 (32) 8062-8074
    CrossrefPubMedGoogle Scholar
  • 57 Guo HF, Dai WW, Qian DH. , et al. A simply prepared small-diameter artificial blood vessel that promotes in situ endothelialization. Acta Biomater 2017; 54 (17) 107-116
    CrossrefPubMedGoogle Scholar
  • 58 Sierra JR, Corso S, Caione L. , et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med 2008; 205 (07) 1673-1685
    CrossrefPubMedGoogle Scholar
  • 59 Zhou H, Yang YH, Binmadi NO, Proia P, Basile JR. The hypoxia-inducible factor-responsive proteins semaphorin 4D and vascular endothelial growth factor promote tumor growth and angiogenesis in oral squamous cell carcinoma. Exp Cell Res 2012; 318 (14) 1685-1698
    CrossrefPubMedGoogle Scholar
  • 60 Tang J, Wang J, Yang J. , et al. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 2009; 36 (04) 644-650
    CrossrefPubMedGoogle Scholar
  • 61 Zhou B, Han ZC, Poon MC, Pu W. Mesenchymal stem/stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: enhancement of cell recruitment and entrapment. Med Hypotheses 2007; 68 (06) 1268-1271
    CrossrefPubMedGoogle Scholar
  • 62 Mousa SA. Low-molecular-weight heparin in thrombosis and cancer. Semin Thromb Hemost 2004; 30 (Suppl. 01) 25-30
    Article in Thieme ConnectPubMedGoogle Scholar
  • 63 Wojtukiewicz MZ, Sierko E, Zacharski LR. Interfering with hemostatic system components: possible new approaches to antiangiogenic therapy. Semin Thromb Hemost 2004; 30 (01) 145-156
    Article in Thieme ConnectPubMedGoogle Scholar
  • 64 De Falco E, Porcelli D, Torella AR. , et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004; 104 (12) 3472-3482
    CrossrefPubMedGoogle Scholar
  • 65 Broxmeyer HE, Hangoc G, Cooper S, Campbell T, Ito S, Mantel C. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis. Ann N Y Acad Sci 2007; 1106: 1-19
    CrossrefPubMedGoogle Scholar
  • 66 Yin Y, Huang L, Zhao X, Fang Y. AMD3100 mobilizes endothelial progenitor cells in mice, but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell. J Cardiovasc Pharmacol 2007; 50 (01) 61-67
    CrossrefPubMedGoogle Scholar
  • 67 Broxmeyer HE, Orschell CM, Clapp DW. , et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005; 201 (08) 1307-1318
    CrossrefPubMedGoogle Scholar
  • 68 Gallagher KA, Liu ZJ, Xiao M. , et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007; 117 (05) 1249-1259
    CrossrefPubMedGoogle Scholar